Interpace Biosciences Announces Update of Previously Announced CMS Billing Policy Impacting its Thyroid Tests
22. Februar 2022 09:00 ET
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, announced today that the...